Dr. Perez is a cancer specialist and an internationally known translational researcher. Her other roles group vice chair of the Alliance for Clinical Trials in Oncology and other positions within the American Association for Cancer Research, the American Society of Clinical Oncology and the National Cancer Institute. Dr. Perez has authored more than 700 research articles in journals, books and abstract, and serves on the editorial boards of multiple academic journals. Dr. Perez’s areas of focus include developing a wide range of clinical trials exploring targeted therapeutic agents for the treatment and prevention of breast cancer. Dr. Perez is leading studies to evaluate the role of genetic biomarkers in the development, aggressiveness and therapeutic efficacy of therapies for breast cancer. Dr. Perez's goal is to enhance the understanding of biological markers and pathways that drive breast cancer growth and development, as well as speed up access to personalized therapies.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.